Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Echocardiography | 16 | 2021 | 3661 | 1.86 | Why? |
| Ventricular Dysfunction, Right | 7 | 2021 | 639 | 1.71 | Why? |
| Ventricular Function, Right | 5 | 2020 | 388 | 1.45 | Why? |
| Echocardiography, Stress | 5 | 2019 | 65 | 1.42 | Why? |
| Cardiomegaly, Exercise-Induced | 4 | 2019 | 10 | 1.28 | Why? |
| Heart Ventricles | 9 | 2019 | 1139 | 1.20 | Why? |
| Heart Atria | 5 | 2019 | 267 | 1.17 | Why? |
| Echocardiography, Doppler | 5 | 2018 | 269 | 1.03 | Why? |
| Ventricular Dysfunction, Left | 4 | 2021 | 993 | 1.03 | Why? |
| Pulmonary Circulation | 4 | 2018 | 207 | 0.95 | Why? |
| Heart | 5 | 2019 | 1791 | 0.86 | Why? |
| Cardiomyopathies | 3 | 2018 | 997 | 0.79 | Why? |
| Testosterone Congeners | 1 | 2018 | 9 | 0.77 | Why? |
| Hypertension, Pulmonary | 9 | 2020 | 970 | 0.77 | Why? |
| Arterial Pressure | 1 | 2020 | 208 | 0.73 | Why? |
| Atrial Function, Left | 1 | 2018 | 82 | 0.70 | Why? |
| Athletes | 4 | 2019 | 1047 | 0.68 | Why? |
| Adaptation, Physiological | 2 | 2018 | 359 | 0.67 | Why? |
| Diastole | 2 | 2017 | 168 | 0.67 | Why? |
| Metabolism, Inborn Errors | 1 | 2017 | 51 | 0.66 | Why? |
| Physical Endurance | 1 | 2017 | 107 | 0.61 | Why? |
| Ventricular Remodeling | 1 | 2019 | 349 | 0.59 | Why? |
| Elasticity Imaging Techniques | 1 | 2017 | 194 | 0.57 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2017 | 219 | 0.55 | Why? |
| Pulmonary Artery | 2 | 2020 | 803 | 0.54 | Why? |
| Heart Diseases | 4 | 2018 | 3503 | 0.53 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.47 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 595 | 0.45 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.43 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 839 | 0.41 | Why? |
| Stroke Volume | 4 | 2021 | 2153 | 0.40 | Why? |
| Sports | 1 | 2017 | 690 | 0.37 | Why? |
| Atrial Function, Right | 2 | 2018 | 13 | 0.36 | Why? |
| Vascular Resistance | 2 | 2018 | 148 | 0.34 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.32 | Why? |
| Coronary Artery Disease | 1 | 2021 | 2570 | 0.31 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.29 | Why? |
| Cardiologists | 2 | 2021 | 366 | 0.28 | Why? |
| Substance-Related Disorders | 1 | 2018 | 2038 | 0.27 | Why? |
| Air Pollution | 1 | 2021 | 3504 | 0.24 | Why? |
| Prognosis | 10 | 2021 | 32490 | 0.21 | Why? |
| Cardiac Catheterization | 2 | 2018 | 882 | 0.21 | Why? |
| Tachycardia, Supraventricular | 1 | 2020 | 52 | 0.21 | Why? |
| Heart Failure | 2 | 2021 | 6638 | 0.21 | Why? |
| Reference Values | 3 | 2018 | 795 | 0.21 | Why? |
| Cardiac Pacing, Artificial | 1 | 2021 | 160 | 0.20 | Why? |
| Functional Residual Capacity | 1 | 2018 | 17 | 0.20 | Why? |
| Exercise | 3 | 2018 | 6771 | 0.19 | Why? |
| Cardiac Volume | 1 | 2018 | 10 | 0.19 | Why? |
| Arrhythmias, Cardiac | 3 | 2021 | 2510 | 0.19 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.18 | Why? |
| Systole | 2 | 2017 | 252 | 0.17 | Why? |
| Undifferentiated Connective Tissue Diseases | 1 | 2017 | 60 | 0.17 | Why? |
| Tachycardia, Ventricular | 1 | 2020 | 251 | 0.17 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2018 | 94 | 0.17 | Why? |
| Raynaud Disease | 1 | 2017 | 86 | 0.16 | Why? |
| Ventricular Dysfunction | 1 | 2017 | 150 | 0.16 | Why? |
| Sodium Chloride | 1 | 2018 | 203 | 0.16 | Why? |
| Diagnosis, Differential | 3 | 2021 | 7220 | 0.15 | Why? |
| Hemodynamics | 3 | 2019 | 1562 | 0.15 | Why? |
| Multimodal Imaging | 1 | 2020 | 534 | 0.15 | Why? |
| Image Enhancement | 1 | 2017 | 177 | 0.15 | Why? |
| Blood Gas Analysis | 1 | 2018 | 893 | 0.14 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.14 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.14 | Why? |
| Dyslipidemias | 1 | 2021 | 791 | 0.14 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.13 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.13 | Why? |
| Italy | 8 | 2021 | 38444 | 0.13 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.13 | Why? |
| Humans | 38 | 2021 | 930598 | 0.13 | Why? |
| Rehabilitation | 1 | 2019 | 386 | 0.13 | Why? |
| Exercise Tolerance | 1 | 2018 | 634 | 0.13 | Why? |
| Male | 21 | 2021 | 367725 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.11 | Why? |
| Positron-Emission Tomography | 1 | 2017 | 802 | 0.11 | Why? |
| Coronary Disease | 1 | 2017 | 645 | 0.11 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.11 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.11 | Why? |
| Scleroderma, Systemic | 1 | 2017 | 583 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Ventricular Function, Left | 1 | 2019 | 1555 | 0.10 | Why? |
| Exercise Therapy | 1 | 2019 | 976 | 0.10 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.10 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.10 | Why? |
| Transposition of Great Vessels | 1 | 2009 | 30 | 0.10 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.10 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Aged | 16 | 2021 | 215776 | 0.09 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.09 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.09 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.08 | Why? |
| Evidence-Based Medicine | 2 | 2019 | 3228 | 0.08 | Why? |
| Chronic Disease | 2 | 2019 | 5139 | 0.08 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.08 | Why? |
| Adult | 11 | 2020 | 244371 | 0.08 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2017 | 11304 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.08 | Why? |
| Atrial Fibrillation | 1 | 2020 | 2320 | 0.08 | Why? |
| Risk Assessment | 5 | 2021 | 25439 | 0.07 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Coronary Stenosis | 1 | 2006 | 273 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.06 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.05 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Vascular Remodeling | 1 | 2019 | 99 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Coronary Vessels | 1 | 2006 | 914 | 0.05 | Why? |
| Syncope | 1 | 2020 | 238 | 0.04 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.04 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.04 | Why? |
| Echocardiography, Three-Dimensional | 1 | 2017 | 135 | 0.04 | Why? |
| Myocardial Perfusion Imaging | 1 | 2018 | 218 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2019 | 25144 | 0.04 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.04 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2020 | 453 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2019 | 1425 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2020 | 2654 | 0.02 | Why? |
| Regional Blood Flow | 1 | 2006 | 172 | 0.02 | Why? |
| Blood Flow Velocity | 1 | 2006 | 193 | 0.02 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Patient Safety | 1 | 2019 | 4885 | 0.02 | Why? |
| Ultrasonography, Doppler | 1 | 2006 | 406 | 0.02 | Why? |
| Cardiology | 1 | 2018 | 2873 | 0.02 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| ROC Curve | 1 | 2006 | 6024 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2009 | 9537 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Logistic Models | 1 | 2006 | 9089 | 0.01 | Why? |
D'Andrea's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(249)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_